17-7592777-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004860.4(FXR2):c.1646G>A(p.Arg549His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R549C) has been classified as Uncertain significance.
Frequency
Consequence
NM_004860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FXR2 | NM_004860.4 | c.1646G>A | p.Arg549His | missense_variant | 14/17 | ENST00000250113.12 | |
FXR2 | XM_047437106.1 | c.1646G>A | p.Arg549His | missense_variant | 14/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FXR2 | ENST00000250113.12 | c.1646G>A | p.Arg549His | missense_variant | 14/17 | 1 | NM_004860.4 | P1 | |
FXR2 | ENST00000704984.1 | c.1865G>A | p.Arg622His | missense_variant | 14/17 | ||||
MPDU1 | ENST00000423172.6 | c.*305C>T | 3_prime_UTR_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000110 AC: 27AN: 245680Hom.: 0 AF XY: 0.0000971 AC XY: 13AN XY: 133890
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461314Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 726938
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151998Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74220
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.1646G>A (p.R549H) alteration is located in exon 14 (coding exon 14) of the FXR2 gene. This alteration results from a G to A substitution at nucleotide position 1646, causing the arginine (R) at amino acid position 549 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at